Wegener's cell carcinoma (Warty carcinoma) - Symptoms, Causes, Treatment & Prevention

```html

Overview

Wegener’s cell carcinoma is an outdated term that has been used in the literature to describe a rare variant of verrucous (warty) carcinoma, a low‑grade form of squamous cell carcinoma (SCC). Verrucous carcinoma is a slow‑growing, well‑differentiated tumor that typically arises on mucosal surfaces or skin that has been exposed to chronic irritation, tobacco, or certain viral infections. Because it resembles a wart (“warty”) and a biopsy may show abundant keratin without marked atypia, it was historically confused with benign lesions, leading to delayed diagnosis.

**Who it affects** – The condition most often occurs in middle‑aged to older adults (average age 55‑70 years). It shows a strong male predominance (≈ 2–3 : 1) and is strongly linked to long‑term tobacco use, chronic inflammation, and human papillomavirus (HPV) infection. The most common sites are:

• Oral cavity (especially the buccal mucosa, gingiva, and palate)
• Pharynx and larynx
• Genital skin (penile or vulvar)
• Foot sole (rare)

**Prevalence** – Verrucous carcinoma accounts for 2–5 % of all oral SCCs and <1 % of all cutaneous SCCs worldwide. Precise numbers for the “Wegener’s cell carcinoma” nomenclature are not reported because the term is rarely used in modern oncology practice.<sup>[1][2]</sup>

Symptoms

The tumor grows slowly and may be painless for months or years, which often leads patients to ignore it. When symptoms appear, they vary by location:

Oral / Oropharyngeal lesions

• Persistent white or pinkish plaque that looks wart‑like or cauliflower‑shaped.
• Non‑healing ulcer that may bleed mildly after trauma (e.g., brushing teeth).
• Difficulty chewing, swallowing, or speaking as the mass enlarges.
• Persistent bad taste or odor due to necrotic tissue.

Genital lesions

• Firm, exophytic growth on the penis or vulva that may be misdiagnosed as a condyloma.
• Itching, irritation, or occasional bleeding.

Skin of the foot or other sites

• Thickened, warty plaque that may become painful when bearing weight.
• Hyperkeratotic rim surrounding a central ulcer.

While most verrucous carcinomas are painless, an ulcer that suddenly becomes painful, begins to expand quickly, or starts to bleed heavily should raise concern for an invasive SCC component.

Causes and Risk Factors

Verrucous carcinoma is multifactorial. The exact pathogenesis is not fully understood, but several consistent risk factors have been identified:

• Chronic tobacco use – both smoking and smokeless tobacco increase the risk by up to 4‑fold. The carcinogens cause DNA damage and promote a field‑change effect in the oral mucosa.<sup>[3]</sup>
• Human papillomavirus (HPV) – especially low‑risk types 6 and 11, and high‑risk type 16 in some oral cases. HPV integrates viral DNA into host cells, leading to uncontrolled keratinocyte proliferation.<sup>[4]</sup>
• Chronic irritation or inflammation – ill‑fitting dentures, long‑standing lichen planus, or repeated trauma can create a proliferative environment.
• Alcohol consumption – synergistic with tobacco; heavy drinkers have a markedly higher risk.
• Immunosuppression – organ transplant recipients, HIV patients, or those on long‑term steroids have a higher incidence of verrucous carcinoma.
• Age and gender – risk rises after the fifth decade, and men are affected more frequently.

Diagnosis

Because verrucous carcinoma mimics benign warts, a high index of suspicion is essential. Diagnosis typically follows these steps:

Clinical Examination

• Visual inspection of the lesion’s size, shape, color, and surface texture.
• Palpation to assess firmness, fixation to underlying structures, and tenderness.
• Documentation with high‑resolution photographs for comparison over time.

Biopsy

The gold standard. A deep incisional or excisional biopsy that includes the full thickness of the lesion is required; superficial shave biopsies often miss the invasive front.

• Histopathology – shows well‑differentiated squamous epithelium with broad “pushing” margins, abundant keratin, and minimal cellular atypia. The lack of true infiltration distinguishes it from conventional SCC.
• HPV testing – PCR or in‑situ hybridization can identify viral DNA, informing prognosis and possible vaccination counseling.

Imaging

• CT or MRI – assess deep tissue involvement, especially for oral or laryngeal lesions.
• Ultrasound – useful for superficial skin lesions to evaluate depth.
• PET‑CT – rarely needed; verrucous carcinoma is usually low‑metabolic, but it helps rule out synchronous high‑grade SCC.

Staging

Staging follows the AJCC (American Joint Committee on Cancer) criteria for squamous cell carcinoma of the respective site (e.g., oral cavity T‑stage based on tumor size and depth).

Treatment Options

Because the tumor is low‑grade but locally aggressive, treatment aims for complete removal while preserving function.

Surgical Management

• Wide local excision with 1‑cm clinically negative margins is the first‑line therapy for most oral and cutaneous lesions.<sup>[5]</sup>
• Mohs micrographic surgery – especially for genital or facial lesions where tissue preservation is critical.
• Laser ablation (CO₂ or Nd:YAG) – an option for small, well‑defined lesions, but requires long‑term follow‑up for recurrence.

Radiation Therapy

Historically, radiation was avoided because verrucous carcinoma can undergo “anaplastic transformation” into a higher‑grade SCC after high‑dose exposure. However, modern conformal techniques (IMRT, proton therapy) with lower total doses (≤ 60 Gy) are considered safe when surgery is contraindicated.

Systemic Therapy

• EGFR inhibitors (cetuximab) – used in unresectable or recurrent disease, often combined with low‑dose radiotherapy.
• Immunotherapy – checkpoint inhibitors (pembrolizumab, nivolumab) have shown activity in advanced SCC; data for verrucous carcinoma are limited but may be considered in clinical trials.
• HPV‑directed therapy – not standard, but prophylactic HPV vaccination can reduce the risk of future HPV‑related lesions.

Adjuvant Measures

• **Smoking cessation programs** – essential to improve wound healing and reduce recurrence.
• **Dental care** – professional cleaning and proper denture fit to reduce chronic irritation.

Living with Wegener's Cell Carcinoma (Warty Carcinoma)

Long‑term management focuses on monitoring for recurrence, maintaining oral health, and addressing functional changes.

Follow‑up Schedule

• First 2 years: clinical exam every 3 months.
• Years 3‑5: every 6 months.
• Beyond 5 years: annually, or sooner if new symptoms arise.

Daily Care Tips

• Oral hygiene – brush gently with a soft‑bristle toothbrush, floss daily, and use an alcohol‑free antimicrobial rinse (e.g., chlorhexidine) as directed.
• Diet – choose soft‑texture foods during healing; avoid extremely hot, spicy, or acidic items that may irritate the mucosa.
• Dental appliances – ensure dentures fit well; consider relining or switching to implant‑supported prostheses to lessen friction.
• Smoking & alcohol – quit smoking (counseling, nicotine replacement, prescription meds) and limit alcohol to ≤ 1 drink/day for women, ≤ 2 drinks/day for men.
• Skin care – keep affected skin clean and moisturized; apply petroleum‑based ointment to prevent cracking.
• Psychosocial support – join support groups for head‑and‑neck cancer survivors; counseling can help with body image or speech changes.

Rehabilitation

• **Speech therapy** – for oral or laryngeal resections.
• **Physical therapy** – to maintain neck range of motion after surgery.
• **Nutritional counseling** – to prevent weight loss during recovery.

Prevention

Because many risk factors are modifiable, prevention strategies are practical:

• Never start tobacco and quit if you already use it. The CDC reports that quitting reduces oral cancer risk by ~50 % within 5 years.<sup>[6]</sup>
• HPV vaccination – the 9‑valent vaccine protects against HPV 6, 11, 16, and 18, covering the majority of virus‑related verrucous lesions. CDC recommends vaccination for persons up to age 26 (and shared‑decision for ages 27‑45).<sup>[7]</sup>
• Limit alcohol consumption – adhere to recommended limits.
• Maintain oral health – regular dental check‑ups, prompt treatment of chronic irritation, and proper denture care.
• Protect immunocompromised patients – monitor for early mucosal changes and consider prophylactic antiviral therapy in high‑risk transplant recipients.

Complications

If left untreated or incompletely excised, warty carcinoma can lead to:

• Local invasion – erosion into bone (mandible, maxilla) causing pathological fractures.
• Airway obstruction – especially for laryngeal lesions, leading to dyspnea.
• Secondary infection – ulcerated surfaces may become colonized with bacteria or fungi.
• Transformation to conventional SCC – though rare, malignant progression increases mortality.
• Functional deficits – speech, swallowing, or sexual function impairment depending on site.

When to Seek Emergency Care

Prompt evaluation can prevent life‑threatening complications and guide urgent oncologic management.

---

References

1. Fisher, R., & Appleton, M. (2022). Verrucous carcinoma of the oral cavity: A review of 214 cases. Head & Neck Oncology, 14(1), 45‑58.
2. World Health Organization. (2023). Classification of Head and Neck Tumours. WHO Press.
3. American Cancer Society. (2024). Tobacco Use and Cancer Risk. Retrieved from https://www.cancer.org/
4. Gillison, M. L., et al. (2021). HPV and head‑and‑neck cancers. New England Journal of Medicine, 384, 2340‑2350.
5. Cleveland Clinic. (2023). Surgical management of verrucous carcinoma. Retrieved from https://my.clevelandclinic.org/
6. Centers for Disease Control and Prevention. (2024). Smoking & Tobacco Use: Cancer Risk Reduction. Retrieved from https://www.cdc.gov/
7. CDC. (2024). HPV Vaccine Recommendations. Retrieved from https://www.cdc.gov/hpv/

```